EuCARE Shines at AREVIR Meeting with Another Illuminating Session
For the third consecutive year, the prestigious AREVIR meeting in Cologne, Germany, welcomed a dedicated session by EuCARE, marking yet another milestone in our collaborative
For the third consecutive year, the prestigious AREVIR meeting in Cologne, Germany, welcomed a dedicated session by EuCARE, marking yet another milestone in our collaborative
We’re thrilled to share that EuCARE will be featured in a special session at the AREVIR Meeting 2024 for the third time! 🎉 Our team
🌟 EuCARE Surpasses 50,000 Patient Milestone! The EuCARE initiative has reached a significant milestone, enrolling over 50,000 patients across its clinical cohorts. These cohorts include
EuCARE partners made contributions to the Conference on Retroviruses and Opportunistic Infections 2024 (CROI), held from March 3rd to 6th, 2024. This prestigious conference, established
How do SARS-COV-2 variants, coupled with other factors, influence the short- and long-term clinical course of COVID-19? Is the efficacy of vaccines or diagnostic tests affected as new variants emerge? Does treatment efficacy vary among variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?
34 institutions from 4 continents collaborate to find answers to these and other crucial questions and to create a sustainable network to promptly tackle similar issues in the future.
FUNDED BY THE EC UNDER HORIZON-HLTH-2021-CORONA-01
- GRANT AGREEMENT NO 101046016
Get to know the project and its scope
Find out all the media news about the EuCARE Project.